Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...
More information: Aitor Morales-Gregorio et al, Neural manifolds in V1 change with top-down signals from V4 targeting the foveal region, Cell Reports (2024). DOI: 10.1016/j.celrep.2024.114371 ...